Teasing Apart Multiple Biologic Failure in Psoriasis, PsA

'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'

Related Keywords

San Francisco ,California ,United States ,France ,Washington ,French ,Christophert Ritchlin ,Trex Bio ,Wilson Liao ,Amgen ,American College Of Rheumatology ,Pfizer ,Skin Treatment Center ,University Of Rochester ,Musculoskeletal Research ,University Of California ,National Psoriasis Foundation ,Novartis ,National Psoriasis ,Skin Treatment ,Psoriasis Area ,Severity Index ,Corevitas Psoriasis Registry ,American College ,Psoriasis ,Prostate Specific Antigen Psa ,Prostate Specific Antigen ,Sa ,Biologic Therapy ,Psoriatic Arthritis ,Prostate Carcinoma ,Alignant Prostate Neoplasm ,Prostate Cancer ,Ancer Prostate ,Genetics ,Refractory ,Health Insurance ,Arthritis ,Oint Inflammation ,Human Leukocyte Antigen ,La Human Leukocyte Antigen ,Hyperlipidemia ,Insurance ,Metabolism ,Etabolic ,Spain ,Adherence ,Dherence To Medicat ,